Article Versions Notes

Lobaina Y, Chen R, Suzarte E, Ai P, Huerta V, Musacchio A, Silva R, Tan C, Martín A, Lazo L, et al. The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality. Viruses. 2024; 16(3):418. https://doi.org/10.3390/v16030418

Lobaina, Yadira, Rong Chen, Edith Suzarte, Panchao Ai, Vivian Huerta, Alexis Musacchio, Ricardo Silva, Changyuan Tan, Alejandro Martín, Laura Lazo, and et al. 2024. "The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality" Viruses 16, no. 3: 418. https://doi.org/10.3390/v16030418

Lobaina, Y., Chen, R., Suzarte, E., Ai, P., Huerta, V., Musacchio, A., Silva, R., Tan, C., Martín, A., Lazo, L., Guillén-Nieto, G., Yang, K., Perera, Y., & Hermida, L. (2024). The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality. Viruses, 16(3), 418. https://doi.org/10.3390/v16030418